Gabelli Funds and Columbia Business School co-hosted their 2nd Annual Healthcare Symposium on November 13, 2020. The panelists included executives from the COVID-19 therapeutic and vaccine front-runners, providers, payors, digital health companies and academia. On this panel we heard from: David Hering, Regional President, North America at Pfizer Vaccines; Dr. Robert Paris, Vice President, Infectious Diseases at Moderna; and Dr. David Weinreich, Senior Vice President, Global Clinical Development at Regeneron Pharmaceuticals. They discussed their Phase III data for their vaccine and antibody drug development and addressed the governments Emergency Use Authorization (EUA), manufacturing capacities, distribution challenges, safety, mutations and durability, age and ethnicity and more. Watch the full video to gain insight into the topics covered during this panel on Vaccines & Therapeutics to Treat COVID-19.
